Biography

Travis Laver

Oncology Service
Small Animal Medicine & Surgery
Veterinary Teaching Hospital
VMD, PhD, DACVIM
Clinical Assistant Professor
Email Me
– OR –
p: 706.542.3221

Biography

Research Interests

  • Comparative oncology
  • Molecular oncology
  • Proteasome inhibition
  • NF-kappaB signaling

Educational Background

EDUCATION

2017, Diplomate American College of Veterinary Internal Medicine (Oncology)

2012, VMD, University of Pennsylvania

2008, PhD, Cell Biology, University of Alabama at Birmingham

2002, Biochemistry and Molecular Biology, Mississippi State University

TRAINING

Residency, Medical oncology, Flint Animal Cancer Center, Colorado State University

Rotating Internship, Veterinary Specialty Hospital of the Carolinas

Teaching Experience

SAMS 5302 – Small animal oncology

SAMS 5350 – Small animal digestive diseases

VETM 5150 – Applied Integrative Material II and III (AIMS II and III)

Selected Publications

  • Lee BM, Clarke D, Watson M, Laver T: Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas. Veterinary and Comparative Oncology, 18(4):590-598. 2020. doi: org/10.1111/vco.12582
  • Grimes JA, Secrest SA, Wallace ML, Laver T, Schmiedt CW: Use of Indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre-operative diagnosis of melanoma or mast cell tumor. Veterinary and Comparative Oncology, 18(4):818-824. 2020. org/10.1111/vco.12592
  • Laver T, Feldhaeusser BR, Robat CS, Baez JL, Cronin KL, Buracco P… Thamm DH: Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003-2015). Canadian Veterinary Journal, 59(9):981-987. 2018
  • LaverT, London CA, Vail DM, Biller BJ, Coy J, Thamm DH: Prospective Evaluation of Toceranib Phosphate in Metastatic Canine Osteosarcoma. Veterinary and Comparative Oncology, 16(1):E23-29. 2017. doi:org/10.1111/vco.12328
  • Zhao X, Laver T, Hong SW, Twitty GB, DeVos A, DeVos M, . . . Nozell SE: An NF-κB p65-cIAP2 Link is Necessary for Mediating Resistance to TNF-α Induced Cell Death in Gliomas. Journal of Neuro-Oncology, 102(3), 367-381. 2011. doi:1007/s11060-010-0346-y
  • Nozell S, Laver T, Moseley D, Nowoslawski L, DeVos M, Atkinson GP, . . . Benveniste EN: The ING4 Tumor Suppressor Attenuates NF-†B Activity at the Promoters of Target Genes. Molecular and Cellular Biology, 28(21), 6632-6645. 2008. doi:1128/MCB.00697-08
  • Laver T, Nozell SE, & Benveniste EN: IFN- β -Mediated Inhibition of IL-8 Expression Requires the ISGF3 Components Stat1, Stat2, and IRF-9. Journal of Interferon & Cytokine Research, 28(1), 13-23. 2008. doi:1089/jir.2007.0062

Service Affiliations

Oncology